Rennova Health, Inc. (RNVA) SEC Filing 8-K Material Event for the period ending Friday, September 27, 2019

SEC Filings

RNVA Registration of Securities

Rennova Health, Inc.

CIK: 931059 Ticker: RNVA

View differences made from one to another to evaluate Rennova Health, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Rennova Health, Inc..


Assess how Rennova Health, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Rennova Health, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors



Material Contracts, Statements, Certifications & more

Rennova Health, Inc. provided additional information to their SEC Filing as exhibits

Ticker: RNVA
CIK: 931059
Form Type: 8-K Corporate News
Accession Number: 0001493152-19-014891
Submitted to the SEC: Wed Oct 02 2019 4:38:28 PM EST
Accepted by the SEC: Wed Oct 02 2019
Period: Friday, September 27, 2019
Industry: Testing Laboratories
  1. Financial Exhibit
  2. New Agreement

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: